Healthcare and Pharma Sectors Seek Preventive Care and Policy Support in Budget 2026

Ahead of Union Budget 2026, healthcare, pharmaceutical, insurance, and health-tech sectors urge stronger focus on preventive care, increased public health spending, and support for domestic manufacturing. Stakeholders call for tax incentives to boost R&D, infrastructure development in tier-2 and tier-3 cities, and policies easing access to innovation and export credit. Rising medical inflation and non-communicable diseases highlight the need for reforms enhancing affordability, technology adoption, and supply resilience across India’s healthcare system.